Serotonin may worsen tinnitus symptoms in new study

New research shows that serotonin, a brain chemical boosted by many antidepressants, can intensify tinnitus. Scientists identified a specific brain circuit in mice that links higher serotonin levels to behaviors mimicking the ringing condition.

A team from Oregon Health & Science University and Anhui University in China published the findings in the Proceedings of the National Academy of Sciences. They used optogenetics to stimulate serotonin-producing neurons and observed increased activity in auditory brain regions, along with tinnitus-like responses in the mice via a modified startle test. The study builds on earlier work from 2017 and matches reports from some patients whose tinnitus worsens on SSRIs.

संबंधित लेख

Lab participants show stress and irritability from inaudible infrasound in a scientific study, with visualized low-frequency waves and cortisol monitors.
AI द्वारा उत्पन्न छवि

Study finds infrasound can raise cortisol and irritability even when people can’t hear it

AI द्वारा रिपोर्ट किया गया AI द्वारा उत्पन्न छवि तथ्य-जाँच किया गया

A small controlled experiment reported in Frontiers in Behavioral Neuroscience found that exposure to infrasound—ultra-low-frequency vibration below the range of human hearing—was associated with higher salivary cortisol and more negative mood ratings, even though participants could not reliably detect when the infrasound was present.

Researchers have shown that stimulating specific brain activity in awake mice produces some of the restorative effects of deep sleep, including improved memory. The team now plans to explore whether a similar approach could work in people.

AI द्वारा रिपोर्ट किया गया

A widely studied anti-aging treatment triggered significant brain damage in mice, according to new research from the University of Connecticut. The drug combination dasatinib plus quercetin caused myelin loss and changes resembling those seen in multiple sclerosis. The findings raise questions about its use in longevity studies and off-label therapies.

A proof-of-concept randomized clinical trial published online May 20, 2026, in JAMA Psychiatry found signals that tocilizumab—an anti-inflammatory drug used for immune-mediated conditions including rheumatoid arthritis—may improve some symptoms in adults with moderate-to-severe depression who had a poor response to antidepressants and evidence of low-grade inflammation.

AI द्वारा रिपोर्ट किया गया

New research indicates that oestrogen levels, which vary across the menstrual cycle, can influence how efficiently some drugs reach the brain in women.

यह वेबसाइट कुकीज़ का उपयोग करती है

हम अपनी साइट को बेहतर बनाने के लिए विश्लेषण के लिए कुकीज़ का उपयोग करते हैं। अधिक जानकारी के लिए हमारी गोपनीयता नीति पढ़ें।
अस्वीकार करें